This session is one of three panels included in BIO's Global Leadership Forum hosted within the Emerging Opportunities and Global Markets Track.

With each passing year, biotechnology becomes more of a globalized technology, with research and commercialization efforts reaching new corners of the world. That said, the global scene still seems to be dominated by a few major economies, primarily the United States and small group of centers of biotech excellence outside the United States. Can the start-up culture of cities such as Boston be replicated abroad? What are the other 65 countries represented at the BIO International Convention doing to catch up? What do they need to do to become more dynamic centers of global biotechnology innovation?

Session ID: 131318